Finding 398697 (2023-003)

Material Weakness
Requirement
M
Questioned Costs
-
Year
2023
Accepted
2024-05-29

AI Summary

  • Core Issue: The Organization failed to include required information in subrecipient agreements and did not monitor subrecipient activities properly.
  • Impacted Requirements: Noncompliance with 2 CFR 200.332(a) and (d) regarding subaward identification and monitoring.
  • Recommended Follow-Up: Improve internal controls to ensure all subrecipient agreements are complete and enhance monitoring processes for compliance with federal requirements.

Finding Text

Finding 2023-003: Noncompliance with Subrecipient Monitoring U.S. Department of Health and Human Services Federal Program: Advanced Nursing Education Workforce Grant Program Federal Assistance Listing Number: 93.247 Federal Award Year: 2023 Repeat Finding: No Criteria: In accordance with 2 CFR 200.332(a), pass-through entities must ensure that every subaward is clearly identified to the subrecipient as a subaward and includes the information listed in 2 CFR 200.332(a)(1) at the time of the subaward and if any of these data elements change, include the changes in subsequent subaward modification. When some of this information is not available, the pass-through entity must provide the best information available to describe the Federal award and subaward. In accordance with 2CFR 200.332(d), pass-through entities must monitor the activities of the subrecipient as necessary to ensure that the subaward is used for authorized purposes, in compliance with Federal statutes, regulations, and the terms and conditions of the subaward; and that subaward performance goals are achieved. Condition: The Organization had memorandum of understanding agreements with each of its subrecipients. However, these agreements did not contain the information required by 2 CFR 200.332(a)(1). The Organization did not request or review the audits of its subrecipients in order to take timely and appropriate action on deficiencies detected through audits, if applicable. The Organization did not have sufficient documentation that internal controls were in place and operating effectively over risk assessment procedures required by the subrecipient monitoring compliance requirement. Cause: The Organization did not have adequate internal controls in place to ensure the agreements with its subrecipients included the required information. Additionally, the Organization did not have adequate controls in place to properly monitor the activities of its subrecipients, or perform the necessary risk assessment procedures. Effect: We tested two out of the four subrecipients the Organization passed funds to under this grant award. Of the two we tested, we noted that the Organization did not have properly executed subrecipient agreements with either subrecipient. We also noted that the Organization did not request the audits of either subrecipient, and did not adequately document its risk assessment. Recommendation: We recommend the Organization enhance its internal controls over the preparation of subrecipient agreements to ensure all required information is contained in the agreements. We also recommend that management enhance its internal controls over subrecipient monitoring to ensure that its subrecipients are utilizing the funds for authorized purposes, in compliance with Federal statutes, regulations, and the terms and conditions of the subaward. View of responsible officials of the auditee: Management agrees with the finding and recommendation.

Corrective Action Plan

Tapestry’s Finance team will correct noncompliance with Subrecipient Monitoring by updating the policies and procedures and educating the Finance and Grants team regarding the necessary steps to achieve proper compliance. Furthermore, Tapestry teams will store evidence of monthly meetings with grantees, and ensure we receive proper monitoring documentation to accompany suspended & debarred searches, audits, etc. Tapestry will share these requirements with grantees and ensure our policies and contract language are updated to reflect the CFR rules. The anticipated completion date to correct the Finding 2023-003 is August 15th, 2024.

Categories

Subrecipient Monitoring

Other Findings in this Audit

  • 398693 2023-005
    Significant Deficiency
  • 398694 2023-005
    Significant Deficiency
  • 398695 2023-005
    Significant Deficiency
  • 398696 2023-005
    Significant Deficiency
  • 398698 2023-005
    Significant Deficiency
  • 398699 2023-004
    Material Weakness
  • 398700 2023-004
    Material Weakness
  • 398701 2023-004
    Material Weakness
  • 398702 2023-002
    Material Weakness
  • 398703 2023-002
    Material Weakness
  • 398704 2023-002
    Material Weakness
  • 398705 2023-002
    Material Weakness
  • 398706 2023-002
    Material Weakness
  • 975135 2023-005
    Significant Deficiency
  • 975136 2023-005
    Significant Deficiency
  • 975137 2023-005
    Significant Deficiency
  • 975138 2023-005
    Significant Deficiency
  • 975139 2023-003
    Material Weakness
  • 975140 2023-005
    Significant Deficiency
  • 975141 2023-004
    Material Weakness
  • 975142 2023-004
    Material Weakness
  • 975143 2023-004
    Material Weakness
  • 975144 2023-002
    Material Weakness
  • 975145 2023-002
    Material Weakness
  • 975146 2023-002
    Material Weakness
  • 975147 2023-002
    Material Weakness
  • 975148 2023-002
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
93.527 Affordable Care Act (aca) Grants for New and Expanded Services Under the Health Center Program $4.77M
93.224 Covid-19 - Consolidated Health Centers (community Health Centers, Migrant Health Centers, Health Care for the Homeless, and Public Housing Primary Care) $2.49M
93.527 Covid-19 - Affordable Care Act (aca) Grants for New and Expanded Services Under the Health Center Program $1.16M
93.224 Consolidated Health Centers (community Health Centers, Migrant Health Centers, Health Care for the Homeless, and Public Housing Primary Care) $581,743
93.788 Opioid Str $383,798
93.323 Epidemiology and Laboratory Capacity for Infectious Diseases (elc) $308,830
93.526 Affordable Care Act (aca) Grants for Capital Development in Health Centers $288,337
93.566 Refugee and Entrant Assistance_state Administered Programs $170,000
93.994 Maternal and Child Health Services Block Grant to the States $153,840
93.332 Cooperative Agreement to Support Navigators in Federally-Facilitated and State Partnership Marketplaces $128,294
93.323 Covid-19 - Epidemiology and Laboratory Capacity for Infectious Diseases (elc) $61,089
93.247 Advanced Nursing Education Grant Program $59,275
93.217 Family Planning_services $53,680
93.110 Maternal and Child Health Federal Consolidated Programs $17,500